Journal of Postgraduate Medicine
 Open access journal indexed with Index Medicus & EMBASE  
     Home | Subscribe | Feedback  

NEWS AND FILLER
[Download PDF
 
Year : 2010  |  Volume : 56  |  Issue : 3  |  Page : 191  

Discovery of valproate

N Gogtay 
 Department of Clinical Pharmacology, Seth GS Medical College and KEM Hospital, Mumbai 400012, India

Correspondence Address:
N Gogtay
Department of Clinical Pharmacology, Seth GS Medical College and KEM Hospital, Mumbai 400012
India




How to cite this article:
Gogtay N. Discovery of valproate.J Postgrad Med 2010;56:191-191


How to cite this URL:
Gogtay N. Discovery of valproate. J Postgrad Med [serial online] 2010 [cited 2022 Dec 7 ];56:191-191
Available from: https://www.jpgmonline.com/text.asp?2010/56/3/191/68644


Full Text

The anti-convulsant effect of sodium valproate was discovered serendipitously in 1962 by Pierre Emymard who was working on the effect of khelline derivatives for his thesis. At that time, valproate was being used as a vehicle by two of his colleagues, H Meunier and Y Meunier to dissolve water insoluble compounds. Eymard in his experiments found that the vehicle control (valproate alone) produced significant anti-epileptic effect in rats. Meunier who used valproate to dissolve coumarin also found similar results in rabbits. Their findings were published in the French journal Therapie in 1963 and the first formulation of valproate "Depakine" was launched in France in 1967, 5 years later by Berthier Labs for whom Meunier and Meunier worked.

 
Wednesday, December 7, 2022
 Site Map | Home | Contact Us | Feedback | Copyright  and disclaimer